225-05-3001

FDA and General Services Administration (GSA) agree to work together to accomplish the removal of mercury-contaminated laboratory waste plumbing system and to coordinate with its contractors the hazmat removal and demolition of F08.

225-04-8000A

Transfer of records from FDA to the National Library of Medicine (NIH) to ensure the preservation of and access to these historically significant records.

225-04-4001

Allows FDA to commission Custom and Border Protection Officers.

225-04-8000B

Collaboration between FDA and AoA to support education and information initiatives for older Hispanic Americans to promote health.

225-03-7000

To ensure that sponsors of new antimicrobial animal drugs have access to an effective means for evaluating the effects of their drugs on current FSIS detection tests.

225-18-017

Provides a framework for coordination and collaborative efforts between these two entities in the Department of Health and Human Services.  Replaces 225-13-009.

225-00-8001

Designed to implement the nondiscrimination provisions applicable to programs and activities receiving Federal financial assistance from FDA and to make civil rights an essential part of every program in the Department.

225-99-6001

Transfer of CLIA Complexity Categorization Functions from CDC to FDA

225-99-2001

To facilitate an exchange of information between FDA and FSIS about establishments and operations that are subject to the jurisdiction of both agencies.

225-99-3001

Establishes a relationship between CDER and the Pharmacology and Experimental Therapeutics Section (PETS) so that joint experiments can be conducted relating to drug metabolism and drug-drug interaction.

225-99-6000

Outlines the mechanism for cooperation between CDRH and FAA in matters concerning operation of lasers in airspace

225-98-8000

FDA and the Indian Health Service will work to develop more cohesive relationship to mutually address American Indian and Alaska Native issues within each.